Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

55.66 +1.50 (+2.76%)
Streaming Delayed Price Updated: 10:22 AM EDT, Apr 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
From PROCEPT BioRobotics
Via GlobeNewswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Preview For PROCEPT BioRobotics
Via Benzinga
Earnings Preview For PROCEPT BioRobotics
Via Benzinga
Expert Ratings for PROCEPT BioRobotics
Via Benzinga
Expert Ratings for PROCEPT BioRobotics
Via Benzinga
Why Shares of Procept Biorobotics Were Slumping Thursday
The company released first-quarter earnings on Thursday morning. 
Via The Motley Fool
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... 
Via Benzinga
Expert Ratings for PROCEPT BioRobotics
Within the last quarter, PROCEPT BioRobotics (NASDAQ:PRCT) has observed the following analyst ratings: 
Via Benzinga
Earnings Scheduled For April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter. 
Via Benzinga
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago
From PROCEPT BioRobotics
Via GlobeNewswire
Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence
From PROCEPT BioRobotics
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 469 companies hit new 52-week lows. 
Via Benzinga
PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Corp. to Present at the 43rd Annual Cowen Health Care Conference in Boston
From PROCEPT BioRobotics
Via GlobeNewswire
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
PROCEPT BioRobotics Announces Preliminary Fourth Quarter and Fiscal Year 2022 Revenue
PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023 
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Corp. to Present at the 41st Annual J.P. Morgan Healthcare Conference
From PROCEPT BioRobotics
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About PROCEPT BioRobotics
Over the past 3 months, 4 analysts have published their opinion on PROCEPT BioRobotics (NASDAQ:PRCT) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2022
Upgrades 
Via Benzinga
PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics Announces $52 Million Debt Refinancing
From PROCEPT BioRobotics
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.